0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, a) 250 mL Hospira LifeCare Bag (NDC 61553-197-50), b) 250 mL Hospira LifeCare Bag (NDC 61553-197-50), c) 150 mL Baxter Intravia Bag (NDC 61553-189-48), d) 250 mL Baxter VIAFLEX Bag ( NDC 61553-197-02), e) 250 mL White Smiths Medical Cassette (NDC 615530-933-11) f) 250 mL Yellow Smiths Medical Cassette (NDC 61553-190-50), Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141 ;
Published July 27, 2016 · Recall initiated: May 5, 2016
Summary
FDA records drug Class II recall D-1362-2016, published July 27, 2016 and initiated May 5, 2016. Recalling firm: Pharmedium Services, LLC; Status: Terminated; Reported quantity: 2,194 bags and cassettes; Lot: Service Code 2H8197 , Lot Number 160730048M , Exp. Date 6/12/2016 ; Service Code 2H8197 , Lot Number 160840111M , Exp. Date 6/22/2016 ; Service Code 2H8197 , Lot Number 160870066M , Exp. Date 6/25/2016 ; Service Code 2H8197 , Lot Number 160880208M , Exp. Date 6/27/2016 ; Service Code 2H8197 , Lot Number 160910038M , Exp. Date 6/29/2016 ; Service Code 2K8189 , Lot Number 160730049M , Exp. Date 6/11/2016 ; Service Code 2K8189 , Lot Number 160810152M , Exp. Date 6/20/2016 ; Service Code 2K8189 , Lot Number 160820330M , Exp. Date 6/21/2016 ; Service Code 2K8189 , Lot Number 160940135M , Exp. Date 7/3/2016 ; Service Code 2K8189 , Lot Number 160960178M , Exp. Date 7/5/2016 ; Service Code 2K8189 , Lot Number 160970201M , Exp. Date 7/6/2016 ; Service Code 2K8197 , Lot Number 160660178M , Exp. Date 6/5/2016 ; Service Code 2K8197 , Lot Number 160670161M , Exp. Date 6/6/2016 ; Service Code 2K8197 , Lot Number 160730253M , Exp. Date 6/12/2016 ; Lot # 160770186M; Exp. 06/16 Lot # 160810189M; Exp. 06/16 Lot # 160840050M; Exp. 06/16 Lot # 160890231M; Exp. 06/16 Lot # 160910228M; Exp. 06/16 Lot # 160560020M; Exp. 05/16 Lot # 160610020C; Exp. 05/16 Lot # 160630014C; Exp. 06/16 Lot # 160660007C; Exp. 06/16 Lot # 160670052C; Exp. 06/16 Lot # 160680067C; Exp. 06/16 Lot # 160740037C; Exp. 06/16 Lot # 160740038C; Exp. 06/16 Lot # 160810067C; Exp. 06/16 Lot # 160840174M; Exp. 06/16 Lot # 160880157M; Exp. 06/16 Lot # 169000103M; Exp. 06/16 Lot # 160600222M; Exp. 05/16 Lot # 160740168M; Exp. 05/16 Lot # 160810051C ;Exp. 05/16 Lot # 160830031C; Exp. 06/16 Lot # 160880019C; Exp. 06/16 Lot # 160880175M; Exp. 06/16 Lot # 160950002C; Exp. 06/16 Lot # 160960172M; Exp. 07/16 Lot # 160950133M; Exp. 07/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharmedium Services, LLC
- Distributor
- Nationwide
- Lot
- Service Code 2H8197 , Lot Number 160730048M , Exp. Date 6/12/2016 ; Service Code 2H8197 , Lot Number 160840111M , Exp. Date 6/22/2016 ; Service Code 2H8197 , Lot Number 160870066M , Exp. Date 6/25/2016 ; Service Code 2H8197 , Lot Number 160880208M , Exp. Date 6/27/2016 ; Service Code 2H8197 , Lot Number 160910038M , Exp. Date 6/29/2016 ; Service Code 2K8189 , Lot Number 160730049M , Exp. Date 6/11/2016 ; Service Code 2K8189 , Lot Number 160810152M , Exp. Date 6/20/2016 ; Service Code 2K8189 , Lot Number 160820330M , Exp. Date 6/21/2016 ; Service Code 2K8189 , Lot Number 160940135M , Exp. Date 7/3/2016 ; Service Code 2K8189 , Lot Number 160960178M , Exp. Date 7/5/2016 ; Service Code 2K8189 , Lot Number 160970201M , Exp. Date 7/6/2016 ; Service Code 2K8197 , Lot Number 160660178M , Exp. Date 6/5/2016 ; Service Code 2K8197 , Lot Number 160670161M , Exp. Date 6/6/2016 ; Service Code 2K8197 , Lot Number 160730253M , Exp. Date 6/12/2016 ; Lot # 160770186M; Exp. 06/16 Lot # 160810189M; Exp. 06/16 Lot # 160840050M; Exp. 06/16 Lot # 160890231M; Exp. 06/16 Lot # 160910228M; Exp. 06/16 Lot # 160560020M; Exp. 05/16 Lot # 160610020C; Exp. 05/16 Lot # 160630014C; Exp. 06/16 Lot # 160660007C; Exp. 06/16 Lot # 160670052C; Exp. 06/16 Lot # 160680067C; Exp. 06/16 Lot # 160740037C; Exp. 06/16 Lot # 160740038C; Exp. 06/16 Lot # 160810067C; Exp. 06/16 Lot # 160840174M; Exp. 06/16 Lot # 160880157M; Exp. 06/16 Lot # 169000103M; Exp. 06/16 Lot # 160600222M; Exp. 05/16 Lot # 160740168M; Exp. 05/16 Lot # 160810051C ;Exp. 05/16 Lot # 160830031C; Exp. 06/16 Lot # 160880019C; Exp. 06/16 Lot # 160880175M; Exp. 06/16 Lot # 160950002C; Exp. 06/16 Lot # 160960172M; Exp. 07/16 Lot # 160950133M; Exp. 07/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 254.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 508.00January 1, 2020
- FDAFentanyl Citrate 2 mcg per mL (200 mcg per 100 mL) and Ropivacaine HCl 0.2% in Sodium Chloride 0.9%,December 26, 2018
- FDA0.05 mg/mL Morphine Sulfate and 0.0625% Bupivacaine HCI (Preservative Free) in 0.9% Sodium Chloride, 250 mLJuly 27, 2016
- FDA0.1 mg/mL Morphine Sulfate and 0.05% Bupivacaine HCI (Preservative Free) in 0.9%, 150 mL in 250 mL HospiraJuly 27, 2016
Questions about this recall
Was 0.0625% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, a) 250 mL Hospira LifeCare Bag (NDC 61553-197-50), b) 250 mL Hospira LifeCare Bag (NDC 61553-197-50), c) 150 mL Baxter Intravia Bag (NDC 61553-189-48), d) 250 mL Baxter VIAFLEX Bag ( NDC 61553-197-02), e) 250 mL White Smiths Medical Cassette (NDC 615530-933-11) f) 250 mL Yellow Smiths Medical Cassette (NDC 61553-190-50), Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141 ; recalled?
Yes. FDA published recall D-1362-2016 on July 27, 2016. Reported hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail